Integrative Analysis Identified a 6-miRNA Prognostic Signature in Nasopharyngeal Carcinoma
BackgroundNasopharyngeal carcinoma (NPC) is an Epstein–Barr virus-associated epithelial malignancy, which is rare in America but endemic in China. The current clinical gold TNM-based standard for prognosis may not be enough. Although some studies have reported that some miRNAs have a prognostic powe...
Main Authors: | Yunqin Chen, Zhen Wang, Hong Li, Yixue Li |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-07-01
|
Series: | Frontiers in Cell and Developmental Biology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fcell.2021.661105/full |
Similar Items
-
Identification of an 8-miRNA signature as a potential prognostic biomarker for glioma
by: Baowei Ji, et al.
Published: (2020-09-01) -
Development and Validation of a 6-miRNA Prognostic Signature in Spinal Chordoma
by: Wei Huang, et al.
Published: (2020-10-01) -
Development and clinical validation of a 3-miRNA signature to predict prognosis of gastric cancer
by: Wenqian Qi, et al.
Published: (2021-02-01) -
A Clinical Update on the Prognostic Effect of microRNA Biomarkers for Survival Outcome in Nasopharyngeal Carcinoma: A Systematic Review and Meta-Analysis
by: Peter Shaw, et al.
Published: (2021-08-01) -
Profiling miRNAs in nasopharyngeal carcinoma FFPE tissue by microarray and Next Generation Sequencing
by: Jin Peng, et al.
Published: (2014-12-01)